Human dendritic cells pulsed with specific lipopeptides stimulate autologous antigen-specific T cells without the addition of exogenous maturation factors

Journal of Viral Hepatitis

Volumn 15, Issue 10, 2008, Pages 761-772

  Jones, K L ^a,b   Brown, L E ^c   Eriksson, E M Y ^c   Ffrench, R A ^a,b   Latour, P A ^a,d   Loveland, B E ^a,b   Wall, D M ^e   Roberts, S K ^f   Jackson, D C ^c   Gowans, E J ^a,d,g  

^a MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e PETER MACCALLUM CANCER CENTRE   (Australia)

^f ALFRED HOSPITAL   (Australia)

^g BURNET INSTITUTE   (Australia)

Author keywords

Closed system; Dendritic cells; Free medium; Hapatitis C virus; Lipopeptides; Serum

Indexed keywords

HLA A2 ANTIGEN; INTERFERON; LIPOPEPTIDE; MATURATION PROMOTING FACTOR; PROSTAGLANDIN E; RIBAVIRIN;

ADULT; ARTICLE; CASE REPORT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; HEPATITIS C; HUMAN; MALE; MONOCYTE; PRIORITY JOURNAL;

ADULT; AMINO ACID SEQUENCE; CELL DIFFERENTIATION; COCULTURE TECHNIQUES; CULTURE MEDIA, SERUM-FREE; DENDRITIC CELLS; EPITOPES, T-LYMPHOCYTE; HUMANS; IMMUNOLOGIC MEMORY; LIPOPROTEINS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MONOCYTES; PEPTIDES; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 52149098158     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2008.01003.x     Document Type: Article

References (48)

1. Steinman RM, Cohn Z. Identification of a novel cell type in peripheral lymphoid organs of mice. I: morphology, quantitation, tissue distribution. J Exp Med 1973 137 : 1142 1162.
2. Mondino A, Jenkins MK. Surface proteins involved in T cell costimulation. J Leukoc Biol 1994 55 : 805 815.
3. Dhodapkar MV, Steinman RM, Krasovsky J et al. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med 2001 193 : 233 238.
4. Tsunoda I, Sette A, Fujinamiet RS et al. Lipopeptide particles as the immunologically active component of CTL inducing vaccines. Vaccine 1999 17 : 675 685.
5. Jackson DC, Lau YF, Le T et al. A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses. Proc Natl Acad Sci USA 2004 101 : 15440 15445.
6. Hertz CJ, Kiertscher SM, Godowski PJ et al. Microbial lipopeptides stimulate dendritic cell maturation via Toll-like receptor 2. J Immunol 2001 166 : 2444 2450.
7. Sieling PA, Chung W, Duong BT et al. Toll-like receptor 2 ligands as adjuvants for human Th1 responses. J Immunol 2003 170 : 194 200.
8. Takeda K, Takeuchi O, Akira S. Recognition of lipopeptides by Toll-like receptors. J Endotoxin Res 2002 8 : 459 463.
9. Deliyannis G, Jackson DC, Ede NJ et al. Induction of long-term memory CD8 (+) T cells for recall of viral clearing responses against influenza virus. J Virol 2002 76 : 4212 4221.
10. Deliyannis G, Kedzierska K, Lau YF et al. Intranasal lipopeptide primes lung-resident memory CD8+ T cells for long-term pulmonary protection against influenza. Eur J Immunol 2006 36 : 770 778.
11. BenMohamed L, Thomas A, Druilhe P. Long-term multi epitopic cytotoxic-T-lymphocyte responses induced in chimpanzees by combinations of Plasmodium falciparum liver-stage peptides and lipopeptides. Infect Immun 2004 72 : 4376 4384.
12. Nardin EH, Calvo-Calle M, Oliveira GA et al. A totally synthetic polyoxime malaria vaccine containing Plasmodium falciparum B cell and universal T cell epitopes elicits immune responses in volunteers of diverse HLA types. J Immunol 2001 166 : 481 489.
13. Gahery-Segard H, Pialoux G, Figueiredo S et al. Long-term specific immune responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine: characterization of CD8+-T-cell epitopes recognized. J Virol 2003 77 : 11220 11231.
14. Pialoux G, Gahery-Segard H, Hanne B et al. Lipopeptides induce cell-mediated anti-HIV immune responses in seronegative volunteers. AIDS 2001 15 : 1239 1249.
15. Deres K, Schild H, Wiesmüller K-H et al. In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature 1989 342 : 561 564.
16. Vitiello A, Ishioka G, Grey HM et al. Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans. J Clin Invest 1995 95 : 341 349.
17. Zhu X, Ramos TV, Gras-Masse H et al. Lipopeptide epitopes extended by an N-epsilon-palmitoyl-lysine moiety increase uptake and maturation of dendritic cells through a Toll-like receptor-2 pathway and trigger a Th1-dependent protective immunity. Eur J Immunol 2004 34 : 3102 3114.
18. Hosmalin A, Andrieu M, Loing E et al. Lipopeptide presentation pathway in dendritic cells. Immunol Lett 2001 79 : 97 100.
19. Andrieu M, Loing E, Desoutteret J-F et al. Endocytosis of an HIV-derived lipopeptide into human dendritic cells followed by class I-restricted CD8(+) T lymphocyte activation. Eur J Immunol 2000 30 : 3256 3265.
20. Schjetne KW, Thompson KM, Nilsen N et al. Cutting Edge: link between innate and adaptive immunity: toll-like receptor 2 internalizes antigen for presentation to CD4+ T cells and could be an efficient vaccine target. J Immunol 2003 171 (1 32 36.
21. Bowen DG, Walker CM. Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature 2005 436 : 946 952.
22. Gale M, Foy EM. Evasion of intracellular host defence by hepatitis C virus. Nature 2005 436 : 939 945.
23. Pearlman BL. Hepatitis C treatment update. Am J Med 2004 117 : 344 352.
24. Gowans EJ, Jones KL, Bharadwaj M et al. Prospects for dendritic cell vaccination in persistent infection with hepatitis C virus. J Clin Virol 2004 30 : 283 290.
25. Larsson M. The dendritic cell: the immune system's adjuvant - a strategy to develop a HCV vaccine? Gastroenterology 2006 130 : 603 606.
26. Sarobe P, Lasarte JJ, Casares N et al. Abnormal priming of CD4(+) T cells by dendritic cells expressing hepatitis C virus core and E1 proteins. J Virol 2002 76 : 5062 5070.
27. Wertheimer AM, Miner C, Lewinsohn DM, Sasaki AW, Kaufman E, Rosen HR. Novel CD4+ and CD8+ T-cell determinants within the NS3 protein in subjects with spontaneously resolved HCV infection. Hepatology 2003 37 (3 577 589.
28. Cerny A, McHutchison JG, Pasquinelli C et al. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. J Clin Invest 1995 95 (2 521 530.
29. Battegay M, Fikes J, DiBisceglie AM et al. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. J Virol 1995 69 (4 2462 2470.
30. Jackson M, Smith B, Bevitt DJ et al. Comparison of cytotoxic T-lymphocyte responses to hepatitis C virus core protein in uninfected and infected individuals. J Med Virol 1999 58 : 239 246.
31. Chua BY, Healy A, Cameron PU et al. Maturation of dendritic cells with lipopeptides that represent vaccine candidates for hepatitis C virus. Immunol Cell Biol 2003 81 : 67 72.
32. Jackson DC, Deliyannis G, Eriksson E et al. Dendritic cell immunotherapy of hepatitis C infection: toxicology of lipopeptide-loaded dendritic cells. Int J Pept Res Ther 2005 11 : 1 12.
33. Jonuleit H, Kuhn U, Muller G et al. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol 1997 27 : 3135 3142.
34. Scandella E, Men Y, Gillessen S et al. Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. Blood 2002 100 : 1354 1361.
35. Thimme R, Opitz OG. Interleukin-10 and viral clearance: translation to viral hepatitis. Gastroenterology 2007 132 (7 2611 2672.
36. Heiser A, Coleman D, Dannull J et al. Autologous dendritic cells transfected with prostate-specific RNA stimulate CTL responses against metastatic tumors. J Clin Invest 2002 109 : 409 417.
37. Nair SK, Hull S, Coleman D et al. Induction of carcinoembryonic antigen (CEA)-specific cytotoxic T-lymphocyte responses in vitro using autologous dendritic cells loaded with CEA peptide or CEA RNA in patients with metastatic malignancies expressing CEA. Int J Cancer 1999 82 : 121 124.
38. Legler DF, Krause P, Scandella E et al. Prostaglandin E2 is generally required for human dendritic cell migration and exerts its effect via EP2 and EP4 receptors. J Immunol 2006 176 : 966 973.
39. Elias M, van Zamten J, Hospers GAP et al. Closed system generation of dendritic cells from a single blood volume for clinical application in immunotherapy. J Clin Apher 2005 20 : 197 207.
40. Sorg RV, Özcan Z, Brefort T et al. Clinical-scale generation of dendritic cells in a closed system. J Immunother 2003 26 : 374 383.
41. Tuyaerts S, Noppe SM, Corthals J et al. Generation of large numbers of dendritic cells in a closed system using cell factories. J Immunol Methods 2002 264 : 135 151.
42. Feurstein B, Berger TG, Maczek C et al. A method for the production of cryopreserved aliquots of antigen-preloaded, mature dendritic cells ready for clinical use. J Immunol Methods 2000 245 : 15 29.
43. de Vries IJM, Eggert AAO, Scharenborg NM et al. Phenotypical and functional characterization of clinical grade dendritic cells. J Immunother 2002 25 : 429 438.
44. 2 results in uniform maturation of human monocyte-derived dendritic cells: implications for immunotherapy. Vaccine 2002 20 : A8 A22.
45. Zobywalski A, Javorovic M, Frankenberger B et al. Generation of clinical grade dendritic cells with capacity to produce biologically active IL-12p70. J Transl Med 2007 5 : 18.
46. Bertho N, Adamski H, Toujas L et al. Efficient migration of dendritic cells toward lymph node chemokines and induction of T(H)1 responses require maturation stimulus and apoptotic cell interaction. Blood 2005 106 : 1734 1741.
47. Gelderblom HC, Nijhuis LEJ, de Jong EC et al. Monocyte-derived dendritic cells from chronic HCV patients are not infected but show an immature phenotype and aberrant cytokine profile. Liver Int 2007 27 : 944 953.
48. Takyar SS, Li D-S, Wang Y-H, Trowbridge R, Gowans EJ. Specific detection of minus strand hepatitis C virus RNA by RT-PCR on polyA + purified RNA. Hepatology 2000 32 : 382 387.